Even mild obstructive sleep apnea can cause disruptive symptoms, such as brain fog and fatigue, which may benefit from ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Central sleep apnea (CSA) is a sleep disorder that is less common than ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...

FILE - A woman demonstrates how she puts on her sleep apnea breathing device at her home in Los Angeles Thursday, July 12, 2018. Tirzepatide, used to treat diabetes and obesity, can help with sleep ...

The National Council on Aging reveals that about 30 million people in the US have sleep apnea, but only six million of these people have actually been diagnosed. Sleep apnea is a disorder that causes ...

Curious about the latest updates in the Obstructive Sleep Apnea Pipeline? Click here to explore the therapies and trials ...

From the time he was a toddler, Emilio Jose Miranda-Vallejo had trouble sleeping. But it wasn't just the usual restlessness ...

New research shows obstructive sleep apnea severity increases 18% on weekends compared to weekdays. A sleep expert discusses ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...